HK Stock MarketDetailed Quotes

03759 PHARMARON

Watchlist
  • 10.380
  • +0.430+4.32%
Trading May 6 14:19 CST
18.55BMarket Cap11.34P/E (TTM)

PHARMARON Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Turnover
-1.95%2.67B
12.39%11.54B
15.64%8.56B
21.70%5.64B
29.53%2.72B
37.92%10.27B
39.63%7.4B
41.06%4.63B
41.19%2.1B
45.00%7.44B
Operating income
-1.95%2.67B
12.39%11.54B
15.64%8.56B
21.70%5.64B
29.53%2.72B
37.92%10.27B
39.63%7.4B
41.06%4.63B
41.19%2.1B
45.00%7.44B
Cost of sales
----
-14.21%-7.44B
----
-19.24%-3.6B
----
-36.58%-6.52B
----
-44.17%-3.02B
----
-48.31%-4.77B
Operating expenses
-2.84%-1.8B
-14.21%-7.44B
-16.60%-5.48B
-19.24%-3.6B
-24.28%-1.75B
-36.58%-6.52B
-39.81%-4.7B
-44.17%-3.02B
-44.77%-1.41B
-48.31%-4.77B
Gross profit
-10.55%872.15M
9.22%4.09B
13.95%3.08B
26.31%2.04B
40.16%974.97M
40.31%3.75B
39.34%2.7B
35.59%1.61B
34.47%695.63M
39.45%2.67B
Selling expenses
0.41%-55.47M
-9.87%-252.78M
-18.94%-193.92M
-17.27%-126.78M
-18.95%-55.7M
-47.84%-230.07M
-56.20%-163.04M
-69.63%-108.11M
-46.04%-46.82M
-67.97%-155.62M
Administrative expenses
3.81%-398.61M
-7.75%-1.67B
-17.15%-1.21B
-27.89%-845.44M
-42.63%-414.38M
-70.85%-1.55B
-73.19%-1.04B
-72.34%-661.07M
-54.23%-290.52M
-32.64%-908.21M
Research and development expenses
-21.82%-93.61M
-58.78%-448.28M
-67.22%-296.76M
-117.74%-182.18M
-93.81%-76.84M
-86.02%-282.33M
-61.55%-177.47M
-29.79%-83.67M
-36.27%-39.65M
-44.07%-151.78M
Profit from asset sales
-17,640.70%-20M
----
118.51%248.31K
----
124.01%114K
----
-17.65%-1.34M
----
-9.79%-474.7K
----
Revaluation surplus
-103.94%-1.13M
----
-48.12%40.2M
----
-36.42%28.58M
----
328.45%77.49M
----
205.59%44.96M
----
-Changes in the fair value of other assets
-103.94%-1.13M
----
-48.12%40.2M
----
-36.42%28.58M
----
328.45%77.49M
----
205.59%44.96M
----
Impairment and provision
-48.33%-6.47M
-69.33%-35.83M
-95.17%-23.61M
-69.00%-10.71M
-1,025.65%-4.36M
-106.03%-21.16M
-82.15%-12.1M
-1,443.01%-6.34M
82.86%-387.47K
30.72%-10.27M
-Other impairment is provision
-48.33%-6.47M
-69.33%-35.83M
-95.17%-23.61M
-69.00%-10.71M
-1,025.65%-4.36M
-106.03%-21.16M
-82.15%-12.1M
-1,443.01%-6.34M
82.86%-387.47K
30.72%-10.27M
Operating interest expense
----
----
----
-9.60%-89.03M
----
----
----
-414.60%-81.24M
----
---83.07M
Special items of operating profit
81.86%64.63M
65.17%336.11M
132.75%106.16M
53.44%114.24M
210.94%35.54M
-57.25%203.49M
-72.56%45.61M
623.82%74.45M
-79.84%11.43M
36.33%476.05M
Operating profit
-29.53%331.85M
8.28%2.02B
3.79%1.44B
20.13%897.54M
30.70%470.91M
1.54%1.87B
13.73%1.38B
11.03%747.14M
33.25%360.3M
34.46%1.84B
Financing cost
-61.25%-63.44M
-8.89%-182.19M
32.76%-108.84M
----
2.22%-39.34M
---167.31M
-1,282.67%-161.87M
----
-416.87%-40.23M
----
Share of profits of associates
----
93.84%-2.08M
----
347.40%10.98M
----
-147.12%-33.85M
----
36.52%-4.44M
----
392.47%71.85M
Special items of earning before tax
104.11%204.32K
----
51.46%-7.54M
----
-27.90%-4.97M
----
-349.98%-15.53M
----
-537.69%-3.89M
----
Earning before tax
-37.03%268.62M
10.29%1.84B
9.40%1.32B
22.33%908.53M
34.92%426.6M
-12.80%1.67B
0.41%1.21B
11.53%742.7M
11.93%316.18M
44.84%1.91B
Tax
31.07%-52.7M
18.50%-256.11M
29.20%-186.42M
29.84%-124.46M
3.50%-76.45M
-8.02%-314.25M
-32.55%-263.29M
-49.56%-177.4M
-72.94%-79.23M
-68.77%-290.92M
After-tax profit from continuing operations
-38.33%215.92M
16.98%1.58B
20.16%1.13B
38.70%784.07M
47.77%350.15M
-16.54%1.35B
-5.95%944.18M
3.29%565.3M
0.12%236.95M
41.25%1.62B
Earning after tax
-38.33%215.92M
16.98%1.58B
20.16%1.13B
38.70%784.07M
47.77%350.15M
-16.54%1.35B
-5.95%944.18M
3.29%565.3M
0.12%236.95M
41.25%1.62B
Minority profit
-873.86%-14.64M
14.03%-19.32M
73.33%-4.51M
89.94%-2.03M
115.59%1.89M
45.14%-22.47M
53.15%-16.93M
-14.80%-20.13M
-31.87%-12.13M
-61.29%-40.95M
Profit attributable to shareholders
-33.80%230.56M
16.48%1.6B
18.51%1.14B
34.28%786.09M
39.81%348.26M
-17.24%1.37B
-7.59%961.11M
3.65%585.43M
1.31%249.09M
41.68%1.66B
Basic earnings per share
-33.94%0.13
16.55%0.9033
18.81%0.643
34.85%0.4442
-6.42%0.1968
-44.60%0.775
-38.18%0.5412
-30.67%0.3294
-32.27%0.2103
-5.65%1.3988
Diluted earnings per share
-34.01%0.1298
16.54%0.9019
18.75%0.6421
34.71%0.4436
-6.29%0.1967
-43.47%0.7739
-38.11%0.5407
-30.63%0.3293
-32.20%0.2099
-7.37%1.3691
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
IAS
CAS (2007)
IAS
CAS (2007)
IAS
CAS (2007)
IAS
CAS (2007)
IAS
Audit Opinions
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
--
--
Unqualified Opinion
Auditor
--
Ernst & Young
--
--
--
Ernst & Young
--
--
--
Ernst & Young
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Turnover -1.95%2.67B12.39%11.54B15.64%8.56B21.70%5.64B29.53%2.72B37.92%10.27B39.63%7.4B41.06%4.63B41.19%2.1B45.00%7.44B
Operating income -1.95%2.67B12.39%11.54B15.64%8.56B21.70%5.64B29.53%2.72B37.92%10.27B39.63%7.4B41.06%4.63B41.19%2.1B45.00%7.44B
Cost of sales -----14.21%-7.44B-----19.24%-3.6B-----36.58%-6.52B-----44.17%-3.02B-----48.31%-4.77B
Operating expenses -2.84%-1.8B-14.21%-7.44B-16.60%-5.48B-19.24%-3.6B-24.28%-1.75B-36.58%-6.52B-39.81%-4.7B-44.17%-3.02B-44.77%-1.41B-48.31%-4.77B
Gross profit -10.55%872.15M9.22%4.09B13.95%3.08B26.31%2.04B40.16%974.97M40.31%3.75B39.34%2.7B35.59%1.61B34.47%695.63M39.45%2.67B
Selling expenses 0.41%-55.47M-9.87%-252.78M-18.94%-193.92M-17.27%-126.78M-18.95%-55.7M-47.84%-230.07M-56.20%-163.04M-69.63%-108.11M-46.04%-46.82M-67.97%-155.62M
Administrative expenses 3.81%-398.61M-7.75%-1.67B-17.15%-1.21B-27.89%-845.44M-42.63%-414.38M-70.85%-1.55B-73.19%-1.04B-72.34%-661.07M-54.23%-290.52M-32.64%-908.21M
Research and development expenses -21.82%-93.61M-58.78%-448.28M-67.22%-296.76M-117.74%-182.18M-93.81%-76.84M-86.02%-282.33M-61.55%-177.47M-29.79%-83.67M-36.27%-39.65M-44.07%-151.78M
Profit from asset sales -17,640.70%-20M----118.51%248.31K----124.01%114K-----17.65%-1.34M-----9.79%-474.7K----
Revaluation surplus -103.94%-1.13M-----48.12%40.2M-----36.42%28.58M----328.45%77.49M----205.59%44.96M----
-Changes in the fair value of other assets -103.94%-1.13M-----48.12%40.2M-----36.42%28.58M----328.45%77.49M----205.59%44.96M----
Impairment and provision -48.33%-6.47M-69.33%-35.83M-95.17%-23.61M-69.00%-10.71M-1,025.65%-4.36M-106.03%-21.16M-82.15%-12.1M-1,443.01%-6.34M82.86%-387.47K30.72%-10.27M
-Other impairment is provision -48.33%-6.47M-69.33%-35.83M-95.17%-23.61M-69.00%-10.71M-1,025.65%-4.36M-106.03%-21.16M-82.15%-12.1M-1,443.01%-6.34M82.86%-387.47K30.72%-10.27M
Operating interest expense -------------9.60%-89.03M-------------414.60%-81.24M-------83.07M
Special items of operating profit 81.86%64.63M65.17%336.11M132.75%106.16M53.44%114.24M210.94%35.54M-57.25%203.49M-72.56%45.61M623.82%74.45M-79.84%11.43M36.33%476.05M
Operating profit -29.53%331.85M8.28%2.02B3.79%1.44B20.13%897.54M30.70%470.91M1.54%1.87B13.73%1.38B11.03%747.14M33.25%360.3M34.46%1.84B
Financing cost -61.25%-63.44M-8.89%-182.19M32.76%-108.84M----2.22%-39.34M---167.31M-1,282.67%-161.87M-----416.87%-40.23M----
Share of profits of associates ----93.84%-2.08M----347.40%10.98M-----147.12%-33.85M----36.52%-4.44M----392.47%71.85M
Special items of earning before tax 104.11%204.32K----51.46%-7.54M-----27.90%-4.97M-----349.98%-15.53M-----537.69%-3.89M----
Earning before tax -37.03%268.62M10.29%1.84B9.40%1.32B22.33%908.53M34.92%426.6M-12.80%1.67B0.41%1.21B11.53%742.7M11.93%316.18M44.84%1.91B
Tax 31.07%-52.7M18.50%-256.11M29.20%-186.42M29.84%-124.46M3.50%-76.45M-8.02%-314.25M-32.55%-263.29M-49.56%-177.4M-72.94%-79.23M-68.77%-290.92M
After-tax profit from continuing operations -38.33%215.92M16.98%1.58B20.16%1.13B38.70%784.07M47.77%350.15M-16.54%1.35B-5.95%944.18M3.29%565.3M0.12%236.95M41.25%1.62B
Earning after tax -38.33%215.92M16.98%1.58B20.16%1.13B38.70%784.07M47.77%350.15M-16.54%1.35B-5.95%944.18M3.29%565.3M0.12%236.95M41.25%1.62B
Minority profit -873.86%-14.64M14.03%-19.32M73.33%-4.51M89.94%-2.03M115.59%1.89M45.14%-22.47M53.15%-16.93M-14.80%-20.13M-31.87%-12.13M-61.29%-40.95M
Profit attributable to shareholders -33.80%230.56M16.48%1.6B18.51%1.14B34.28%786.09M39.81%348.26M-17.24%1.37B-7.59%961.11M3.65%585.43M1.31%249.09M41.68%1.66B
Basic earnings per share -33.94%0.1316.55%0.903318.81%0.64334.85%0.4442-6.42%0.1968-44.60%0.775-38.18%0.5412-30.67%0.3294-32.27%0.2103-5.65%1.3988
Diluted earnings per share -34.01%0.129816.54%0.901918.75%0.642134.71%0.4436-6.29%0.1967-43.47%0.7739-38.11%0.5407-30.63%0.3293-32.20%0.2099-7.37%1.3691
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)IASCAS (2007)IASCAS (2007)IASCAS (2007)IASCAS (2007)IAS
Audit Opinions --Unqualified Opinion------Unqualified Opinion------Unqualified Opinion
Auditor --Ernst & Young------Ernst & Young------Ernst & Young

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg